SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Steve's Channelling Thread -- Ignore unavailable to you. Want to Upgrade?


To: Zeev Hed who wrote (22847)8/3/2001 1:27:32 PM
From: xcr600  Respond to of 30051
 
13:15 ET Taro Pharm (TARO) 39.49 -2.36 (-5.6%): Files Abbreviated New Drug Application with the FDA for Loratadine Syrup, a generic equivalent of Schering Corp's Claritin. Company acknowledges news reports stating that Schering has initiated court action to prevent Taro's application from being approved